# 1st Gen Model Cardinal Health, Inc. Drugs, proprietaries, & sundries
at 21-aug-2017
CAH
Model's trade recommendations -12.48% Return for period
-16.14% Annual return
$20.37B Market Cap
β 0.80
CAH
Model (following trade recommendations)CAH
Underlying stockS&P 500
Index- 1.85 (2.87%) Div (Yield)
- HOLD Analysts consensus recommendation
Cardinal Health, Inc. is one of the leading providers of products and services to healthcare providers and manufacturers to help them improve the efficiency and quality of healthcare. These services and products include Pharmaceutical Distribution and Provider Services, Medical-Surgical Products and Services, Pharmaceutical Technologies and Services and Automation and Information Services.
Industry sector: Medical
Sector classification: Drugs, proprietaries, & sundries
Deep Learning based analysis and prediction model for Cardinal Health, Inc. (CAH) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since Oct. 2, 2015.
Market data for CAH model training are being downloaded from the Quandl premium datasets on a daily basis.
Model is being retrained on a daily basis.
| Float | 313M |
| P/E | 11.88 |
| Shares Outstanding | 316M |
| % Held by Insiders | 0.94% |
| % Held by Institutions | 86.41% |
| EPS (last reported FY) | $5.40 |
| EPS (last reported Q) | $1.31 |
| EPS, estimated (last reported Q) | $1.24 |
| Total revenues | $130 B |
| Net income | $1 B |